What Are Hybrid Trials Like For Patients?

Hybrid trials benefit sponsors and CROs by offering increased participant enrollment and retention opportunities. Ultimately, however, the most prominent impact of these patient-centric designs is on the participants. Giving participants the option to complete a portion of their clinical visits at home or in their local communities rather than commuting long distances to clinical sites encourages them to participate in innovative research. But what are they like for participants

Companies benefit from viewing hybrid trials from a patient perspective to adopt a consumer model that benefits the entire study. Modern society has grown used to conducting business from the comfort of their homes, from work to grocery shopping to managing their finances, and they expect quick turnaround times. Pharmaceutical companies benefit from viewing study participants as valuable consumers and finding ways to make participation more accessible and convenient. Patient-centric trials offer tailored support that fits trials into people’s lives while providing invaluable human contact through HCP visits.